Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merlo

Showing results (291-300 of 432) with videos related to

Pageof 44
Sort By:
International Journal of Cardiology|February 5, 2021
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterizationJessica Artico, Marco Merlo, Clint Asher, et al.
ESC Heart Failure|December 12, 2024
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosisAlessia Argirò, Mattia Zampieri, Carlotta Mazzoni, et al.
Scientific Reports|February 17, 2026
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O<sub>2</sub>-pulse in hypertrophic cardiomyopathyMassimo Mapelli, Nikita Baracchini, Nicola Campana, et al.
European Journal of Heart Failure|January 16, 2023
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathyAldostefano Porcari, Yousuf Razvi, Ambra Masi, et al.
Heart (British Cardiac Society)|April 16, 2025
Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathyRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Analytical Chemistry|March 4, 2026
Current Standards and Perspectives in Proteomics for Cardiac AmyloidosisFrancesco Greco, Ellen McPhail, Diana Canetti, et al.
European Heart Journal. Cardiovascular Imaging|March 18, 2024
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosisDaniela Tomasoni, Alberto Aimo, Aldostefano Porcari, et al.
Mayo Clinic Proceedings|May 24, 2025
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac AmyloidosisMattia Zampieri, Annamaria Del Franco, Giulia Biagioni, et al.
European Journal of Heart Failure|May 21, 2026
Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of the ESC Working Group on Myocardial & Pericardial DiseasesPetr Kuchynka, Antonio Brucato, Carsten Tschöpe, et al.
European Heart Journal. Cardiovascular Imaging|June 28, 2023
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosisDaniela Tomasoni, Marianna Adamo, Aldostefano Porcari, et al.
Pageof 44

Showing results (291-300 of 432) with videos related to

Sort By:
Pageof 44
International Journal of Cardiology|February 5, 2021
The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterizationJessica Artico, Marco Merlo, Clint Asher, et al.
ESC Heart Failure|December 12, 2024
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosisAlessia Argirò, Mattia Zampieri, Carlotta Mazzoni, et al.
Scientific Reports|February 17, 2026
Non-invasive stroke volume assessment during cardiopulmonary exercise testing provides additional insight beyond O<sub>2</sub>-pulse in hypertrophic cardiomyopathyMassimo Mapelli, Nikita Baracchini, Nicola Campana, et al.
European Journal of Heart Failure|January 16, 2023
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathyAldostefano Porcari, Yousuf Razvi, Ambra Masi, et al.
Heart (British Cardiac Society)|April 16, 2025
Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathyRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Analytical Chemistry|March 4, 2026
Current Standards and Perspectives in Proteomics for Cardiac AmyloidosisFrancesco Greco, Ellen McPhail, Diana Canetti, et al.
European Heart Journal. Cardiovascular Imaging|March 18, 2024
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosisDaniela Tomasoni, Alberto Aimo, Aldostefano Porcari, et al.
Mayo Clinic Proceedings|May 24, 2025
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac AmyloidosisMattia Zampieri, Annamaria Del Franco, Giulia Biagioni, et al.
European Journal of Heart Failure|May 21, 2026
Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of the ESC Working Group on Myocardial & Pericardial DiseasesPetr Kuchynka, Antonio Brucato, Carsten Tschöpe, et al.
European Heart Journal. Cardiovascular Imaging|June 28, 2023
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosisDaniela Tomasoni, Marianna Adamo, Aldostefano Porcari, et al.
Pageof 44